// App-Quantinova.ai

PB0086 : Thromboembolism in Thalassemia Patients: Is Aspirin Protective against Brain Ischemia over Three Years Follow Up in Beta Thalassemia Patients?

Researchers

Presenter

  • M. Karimi

Principal Investigators

  • S. Haghpanah

  • P. Eshghi

Medical Centers

  • Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Science, Shiraz, Iran, Islamic Republic of

  • Congenital Pediatric Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

Locations

  • Iran

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Ophthalmology (OP)

  • Genetic Disorder

Disease

  • Beta-thalassemia

  • Venous thrombosis

  • Thalassemia

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved